Showing results (161-170 of 262) with videos related to

Sort By:
Pageof 27
Arthritis and Rheumatism|June 1, 1995
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of boneC Roux, C Gennari, J Farrerons, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2000
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment StudyD M Reid, R A Hughes, R F Laan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 6, 2000
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patientsR Eastell, J P Devogelaer, N F Peel, et al.
Gastroenterologie Clinique Et Biologique|April 29, 2009
Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantationA Hollebecque, T Decaens, E Boleslawski, et al.
Gastroenterologie Clinique Et Biologique|November 21, 1998
[Isolated ascites revealing a hypothyroidism. Study of 2 cases]J Desramé, P Mathurin, R Rozov, et al.
Hepatology (Baltimore, Md.)|October 1, 1996
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and durationT Poynard, V Leroy, M Cohard, et al.
European Neurology|January 1, 1991
Hydrocephalus in Guillain-Barré syndromeP Hantson, J L Horn, B Deconinck, et al.
Rheumatology (Oxford, England)|January 17, 2002
Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritisF Jamar, F A Houssiau, J-P Devogelaer, et al.
Clinical Endocrinology|December 1, 1983
Pseudohypoparathyroidism: inheritance and expression of deficient receptor-cyclase coupling protein activityJ A Fischer, H R Bourne, M A Dambacher, et al.
Arthritis and Rheumatism|June 12, 1999
Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesionsD H Manicourt, R D Altman, J M Williams, et al.
Pageof 27